Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer. - Wikidata - awgldk - TriplyDB

Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer.

Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer.

http://www.wikidata.org/entity/Q33816412

about

Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma.Histone deacetylation critically determines T cell subset radiosensitivity.Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma.Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets The prognostic significance of a postoperative systemic inflammatory response in patients with colorectal cancer Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer.High preoperative serum globulin in rectal cancer treated with neoadjunctive chemoradiation therapy is a risk factor for poor outcome.Preoperative platelet lymphocyte ratio as independent predictors of prognosis in pancreatic cancer: A systematic review and meta-analysis.Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal Cancer.Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas.Lymphopenia and its association with survival in patients with locally advanced cervical cancer.Platelet-to-lymphocyte ratio could be a promising prognostic biomarker for survival of colorectal cancer: a systematic review and meta-analysis Systemic release of osteoprotegerin during oxaliplatin-containing induction chemotherapy and favorable systemic outcome of sequential radiotherapy in rectal cancer.Minimum absolute lymphocyte counts during radiation are associated with a worse prognosis in patients with unresectable hepatocellular carcinoma Clinical and molecular diagnosis of pathologic complete response in rectal cancer.Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.Prognostic value of the lymphocyte monocyte ratio in patients with colorectal cancer: A meta-analysis.The impact of the preoperative peripheral lymphocyte count and lymphocyte percentage in patients with colorectal cancer.Nodal tumor response according to the count of peripheral blood lymphocyte subpopulations during preoperative chemoradiotherapy in locally advanced rectal cancer.The lymphocyte-monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy.Prognostic significance of the preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer.Can Neutrophil/Lymphocyte Ratio be a Predictor for Bone Metastases of Solid Tumors?The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type.Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma.Clinicopathological and prognostic significance of high circulating lymphocyte ratio in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.Prognostic impact of preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer with special reference to myeloid-derived suppressor cells Reduction of circulating lymphocyte count is a predictor of good tumor response after neoadjuvant treatment for rectal cancer

P2860

Q26862551-4F5BF29B-A390-451C-BFF7-F6C7A1F99C98 Q33743191-0D462DD0-3FBF-48CA-9DD7-FC661F4C77A3 Q33940805-45F28CE4-8924-4321-92E3-DC2E529905F4 Q34072810-C814E26A-2169-4554-916A-13F9611AF680 Q34566054-028652B3-BC87-4246-9F34-5F7F726DC60C Q34646737-22253E88-2029-42AE-8AC2-371BF7FAD8B0 Q34989668-6DF3D07C-B7F8-4863-AD16-121E4E531F65 Q35083126-EA67C483-1964-4A9E-AE47-A3EC1A7D01E1 Q35701024-5A9CAEA7-A651-4EEF-BDE3-4B52AB8819B4 Q36050510-DE9FAAC3-6808-4C4F-8870-CF60168FF344 Q36250681-58D6B805-92AE-4EAF-8A4C-8C0178DACF79 Q36390876-10A2B84A-B2BA-4011-9962-819FC2271D73 Q36392034-2B45BA06-E2D4-49B7-8F17-C30F43EED034 Q36395269-458B8A14-B0BB-4EDC-9E55-A5A1EB91EFCB Q36569129-20B1D170-852C-423D-B8E8-4211ED69E7CE Q36663622-971BBCC4-80E9-4DC4-8364-5778E28313A5 Q37063842-2A5F50CE-DC92-4A23-A4CD-2316BBE99E07 Q37376421-810F9E75-AC3E-4E6D-B3BA-521CC637D7B4 Q37632272-7A8AFD1D-B92E-4AF0-A801-526DEE589BC0 Q38594617-F76D2D69-C228-42AB-9F7B-9E22C1F203F2 Q39277599-19E191A8-5606-409B-B1D8-A6D8F2260232 Q40435555-4137E818-BF0F-494F-BB2F-9C64C7414DD7 Q40514595-FFA061C6-3E3E-427B-9643-77C5E5DFFE2D Q40568414-30DDA127-744D-4DEA-A5B5-97E937726005 Q42161730-E054B318-1921-4E1C-B85A-C555A88F0BD4 Q42316366-29F3D1DA-2D14-46FC-A9A8-869223498799 Q47109054-BE58D5E6-7FD5-4BB0-BB5E-FE654A81912E Q49110766-68ED6E36-4558-44E5-A628-F9184F078528 Q50744551-57F2D79E-7A19-403E-B854-69E9AF18AF37 Q52718458-1B56750D-3AC2-4DEC-A71F-66F8B99D2B7F Q57700802-66BB37AB-C905-43AA-AF15-FA43EA705F8B Q58704497-1CD60B26-DED3-4260-88FD-185A4B368BD3

P2860

Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer.

http://www.wikidata.org/entity/Q33816412

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Circulating lymphocyte is an i ...... apy in advanced rectal cancer.

@ast

Circulating lymphocyte is an i ...... apy in advanced rectal cancer.

@en

type

label

Circulating lymphocyte is an i ...... apy in advanced rectal cancer.

@ast

Circulating lymphocyte is an i ...... apy in advanced rectal cancer.

@en

prefLabel

Circulating lymphocyte is an i ...... apy in advanced rectal cancer.

@ast

Circulating lymphocyte is an i ...... apy in advanced rectal cancer.

@en

P1433

Q33816412-FCD3FE1F-B19A-47FA-A768-3A796C3E8CEC

P1476

Q33816412-4E968445-42E9-4620-A271-31DE31210CA7

P2093

Q33816412-23481F87-3F5A-4A0C-B88B-52E952761EA8

Q33816412-38CFC874-A834-40E7-ABB7-3B606E123D7E

Q33816412-48DD482F-DCB7-4F55-8458-1FFB7D483E06

Q33816412-510F3BB3-81F2-4E3C-86DF-A91DEA615B0B

Q33816412-FD0B04AF-115E-4B4D-9F6C-40DAD00E1FCA

P2860

Q33816412-0136C54F-CC6F-4B17-B334-E8F735567363

Q33816412-19D47577-A810-4226-AD18-B4D5C3CAFA86

Q33816412-21943D20-D9AD-41B9-A104-CFD6DCA7E855

Q33816412-23BD26F9-7F83-4A14-9317-5A395C6D197C

Q33816412-2896F17F-AA99-4182-B227-FCDB74F7DE19

Q33816412-3E9CBFA5-35D7-4A6A-8714-0DD46D79FB62

Q33816412-502E9828-F748-40F7-BF1B-A918E2334B01

Q33816412-5183946E-729B-4F41-96A7-D2BB36CEB806

Q33816412-55F3AAC1-AEBB-4CFE-ADEC-436291350C9B

Q33816412-66F11C80-3F32-43DB-A795-475821A153EA

P2888

Q33816412-D5C39089-8CAA-463A-84E4-B12857E6D697

P304

Q33816412-289533D2-1108-4879-B969-64F30C94B117

P31

Q33816412-31E5480B-6DEE-4D12-8850-67E94930064F

P356

Q33816412-E12EC6FE-2560-4148-BE09-98481322388A

P407

Q33816412-A12EFAC1-CCE4-4656-9CE0-471C71176B27

P478

Q33816412-146BE930-A427-4660-9958-940AB7473B17

P577

Q33816412-72361FE9-1ECD-43B5-A148-577F2B8544D3

P5875

Q33816412-E404D07E-D4CF-4EF5-82AE-7F4928FCBD7B

P6179

Q33816412-7FB348FD-5273-4857-B7B7-6F3C7218486D

P698

Q33816412-F1F721A1-9C55-4570-BC0C-5FF035A9C11E

P921

Q33816412-7CED9286-9AC4-4C71-B1C7-46440296FB18

P932

Q33816412-46C04BE9-0448-46C1-AFD0-5487AA53A6D8

P356

1471-2407-11-64

P1433

P1476

Circulating lymphocyte is an i ...... apy in advanced rectal cancer.

@en

P2093

Eiji Sunami

http://www.w3.org/2001/XMLSchema#string

Hirokazu Nagawa

http://www.w3.org/2001/XMLSchema#string

Joji Kitayama

http://www.w3.org/2001/XMLSchema#string

Kazushige Kawai

http://www.w3.org/2001/XMLSchema#string

Koji Yasuda

http://www.w3.org/2001/XMLSchema#string

P2860

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Standard treatments induce antigen-specific immune responses in prostate cancer.

Dynamic T(1) mapping predicts outcome of chemoradiation therapy in primary rectal carcinoma: sequence implementation and data analysis.

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.

Radiation and the microenvironment - tumorigenesis and therapy.

Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Chemotherapy with preoperative radiotherapy in rectal cancer.

Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer.

The role of p53 in determining sensitivity to radiotherapy.

A comparison of the acute effects of radiation therapy, including or excluding the thymus, on the lymphocyte subpopulations of cancer patients.

P2888

1471-2407-11-64

P304

64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-11-64

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49822409

http://www.w3.org/2001/XMLSchema#string

P6179

1050797604

http://www.w3.org/2001/XMLSchema#string

P698

21306650

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

3041780

http://www.w3.org/2001/XMLSchema#string